Literature DB >> 8397500

Necrotizing chorioretinitis in mice inoculated with herpes simplex virus type 1 with or without glycoprotein C: anterior chamber-associated immune deviation does not persist.

Y Liu1, H Minagawa, Y Toh, Y Sakai, T Ishibashi, H Inomata, R Mori.   

Abstract

BALB/c mice developed contralateral necrotizing retinitis following intracameral inoculation with herpes simplex virus type 1 (HSV-1). The animals showed a positive delayed-type hypersensitivity (DTH) response at 10 days postinoculation, indicating that the anterior chamber-associated immune deviation was transient after HSV-1 inoculation. Since glycoprotein C (gC) of HSV-1 is a major immunogen, we examined DTH and the antibody response induced by a gC-deficient strain TN-1 and compared them with those induced by the recombinant gC-positive mutants. We found that gC was not required for DTH reaction, and that gC was neither necessary for nor protective against the contralateral retinal necrosis. Serial lymphocyte subset analyses of the draining lymph nodes revealed an absolute increase of B cells, CD4-positive T cells, and CD8-positive T cells. CD4-positive T cells but not CD8-positive T cells increased in the contralateral eyes during the inflammation and necrosis. The coincident emergence of the positive DTH and contralateral retinal necrosis of HSV-1-inoculated mice, together with the presence of CD4-positive cells in the retina, indicated that CD4-positive T cells responsible for DTH induction may participate in the retinal necrosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397500     DOI: 10.1007/bf01309535

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  34 in total

1.  Murine acute retinal necrosis.

Authors:  C S Foster; M Zierhut; H Wu; R Tamesis; N Jabbur
Journal:  Trans Am Ophthalmol Soc       Date:  1991

2.  Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies.

Authors:  L Pereira; D V Dondero; D Gallo; V Devlin; J D Woodie
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

3.  Difference in age distribution of antibody to herpes simplex virus in Fukuoka, Manila and Busan.

Authors:  Y Hayashi; M Nagata; H Yoshizumi; R Mori; C V Navarro; H D Yang
Journal:  Jpn J Med Sci Biol       Date:  1984-02

4.  Herpes simplex virus type-1 strain influence on chorioretinal disease patterns following intracameral inoculation in Igh-1 disparate mice.

Authors:  R Hemady; E M Opremcak; M Zaltas; A Berger; C S Foster
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-08       Impact factor: 4.799

5.  Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes.

Authors:  J U Igietseme; J W Streilein; F Miranda; S J Feinerman; S S Atherton
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells.

Authors:  Y Hidaka; Y Sakai; Y Toh; R Mori
Journal:  J Gen Virol       Date:  1991-04       Impact factor: 3.891

7.  Evidence that precursor cytotoxic T cells mediate acute necrosis in HSV-1-infected retinas.

Authors:  J W Streilein; J U Igietseme; S S Atherton
Journal:  Curr Eye Res       Date:  1991       Impact factor: 2.424

8.  Molecular characterization of naturally occurring glycoprotein C-negative herpes simplex virus type 1.

Authors:  Y Toh; S Tanaka; Y Liu; Y Hidaka; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  An animal model of ocular herpes. Keratitis, retinitis and cataract in the mouse.

Authors:  J R Anderson; H J Field
Journal:  Br J Exp Pathol       Date:  1984-06

10.  Ocular lesions in mice following intracerebral injection of herpes simplex virus type I.

Authors:  R L Peiffer; C D Dekker; F L Siegel
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.